Algert Global LLC Has $3.13 Million Stake in Balchem Co. (NASDAQ:BCPC)

Algert Global LLC grew its holdings in shares of Balchem Co. (NASDAQ:BCPC) by 88.7% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 17,781 shares of the basic materials company’s stock after acquiring an additional 8,360 shares during the period. Algert Global LLC’s holdings in Balchem were worth $3,129,000 as of its most recent SEC filing.

Several other hedge funds have also recently made changes to their positions in BCPC. nVerses Capital LLC acquired a new stake in Balchem during the third quarter worth approximately $35,000. Bessemer Group Inc. grew its position in shares of Balchem by 568.9% during the 1st quarter. Bessemer Group Inc. now owns 301 shares of the basic materials company’s stock worth $47,000 after buying an additional 256 shares during the period. Blue Trust Inc. increased its stake in shares of Balchem by 642.5% in the 3rd quarter. Blue Trust Inc. now owns 839 shares of the basic materials company’s stock valued at $148,000 after acquiring an additional 726 shares in the last quarter. GAMMA Investing LLC lifted its position in shares of Balchem by 73.4% during the 3rd quarter. GAMMA Investing LLC now owns 841 shares of the basic materials company’s stock valued at $148,000 after acquiring an additional 356 shares during the period. Finally, Private Advisor Group LLC bought a new position in Balchem during the third quarter worth $220,000. 87.91% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several equities research analysts have weighed in on the stock. StockNews.com raised shares of Balchem from a “hold” rating to a “buy” rating in a research note on Monday, October 28th. HC Wainwright boosted their target price on Balchem from $185.00 to $190.00 and gave the company a “buy” rating in a research report on Monday, November 4th.

Balchem Price Performance

Shares of NASDAQ:BCPC opened at $182.69 on Tuesday. The stock’s 50 day moving average is $173.84 and its 200-day moving average is $166.71. Balchem Co. has a twelve month low of $120.87 and a twelve month high of $186.03. The company has a quick ratio of 1.90, a current ratio of 2.98 and a debt-to-equity ratio of 0.21. The firm has a market capitalization of $5.94 billion, a price-to-earnings ratio of 49.11, a PEG ratio of 5.45 and a beta of 0.65.

About Balchem

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.